Prostate Cancer Foundation

“Michael milken (chairman) family and business relationship; lori milken (director/vp) family and business relationships; ralph finerman (treasurer/cfo) business elationship; richard sandler (director) business relationship.”

“Form 990 is reviewed by the foundation's ceo, cfo and senior vp finance and administration before distribution to the audit committee for review and final approval. The entire board receives a copy of form 990 and has an opportunity to raise issues prior to being filed.”

“The foundation's board of directors adopted a conflict of interest policy which applies to all directors and officers consistent with the model suggested by the internal revenue service. The policy requires that directors and officers disclose any transactions in which they have a financial interest to the foundation's general counsel. The general counsel is responsible for gathering information and preparing a report regarding any proposed transaction where there is a disclosed financial interest and determining whether or not the transaction reasonably could be determined to meet the foundation's standards for approving a transaction, in which an officer or director has a financial interest (i.e., the best interests of the foundation for the foundation's benefit and fair and reasonable as to the foundation). If pcf's general counsel determines the transaction may meet the approval standard, the transaction is reviewed by and either approved or disapproved by a committee of the board of directors or the entire board of directors consistent with applicable state corporate law requirements. As part of the review process, committee of board of directors is required to identify and evaluate potential alternative transactions which do not involve a foundation officer or director. The interested officer or director is allowed to present information to the committee or board of directors but must leave the meeting at which the transaction is considered prior to the final vote. The foundation's conflict of interest policy also requires officers and directors to complete annual questionnaires wherein they are asked to identify all transactions where they may have an actual or perceived conflict of interest. As part of the questionnaire, each officer and director is required to confirm their understanding that the foundation is a tax exempt entity and must engage primarily in activities which further its mission.the foundation's scientific review panels determine which research projects or types of projects will be funded by the foundation, and also has a conflict of interest policy. Panelists are required to abstain from discussions and votes regarding funding for research projects in which they have a financial or professional interest or institutional affiliation.”

“Staff compensation, including officers and key employees, listed on schedule j are reviewed and approved by the board of directors' compensation committee based on qualifications and market comparability in similar industries. The last compensation review occurred in february 2021.”

“The foundation posts its annual report, audited financial statements and form 990 on its website www.pcf.org (go to "about pcf/where your money goes"). The foundation's governing documents and conflict of interest policy are also posted on the website www.pcf.org.”

“Located in portland, or and san francisco, ca, these new coes join ten other established pcf-va centers in cities across the u.s: philadelphia, pa, washington, dc, durham, nc, tampa bay, fl, seattle, wa, chicago, il, bronx, ny, los angeles, ca, manhattan, ny, and ann arbor, mi. Pcf's veterans health initiative was founded in 2016 as part of the cancer moonshot to ensure veterans, who deserve the very best from our country, receive the very best research and precision oncology care for prostate cancer available through the pcf-va network. For more than 3 million american men and their families fighting prostate cancer and millions more globally, pcf is a primary source for new standard-of-care and research information. Pcf educates the public about prostate cancer risks, screening, prevention, treatment options, and side effects. We connect patients, loved ones, care providers, and scientists to critical updates, the latest developments, best practices, and news from the treatment pipeline. While funding game-changing medical research for prostate cancer is the primary mission of the pcf, hundreds of thousands of patients and their families turn to the foundation as a source for new health information on the disease, prevention, and treatment options as well as the latest developments enabled by pcf's support of basic translational and clinical research. One in eight men and one in seven black men will be diagnosed with prostate cancer in his lifetime. The foundation regularly publishes and distributes informational publications and maintains an active website (www.pcf.org) for patients and caregivers and other audiences engaged with prostate cancer. In 2020, www.pcf.org had more than 2.2 million visits. It also distributes electronic monthly newsletters to an online subscriber base of nearly 180,000 and communicates with audiences daily via social media. Pcf also hosts and funds an annual scientific conference/forum where all the leading prostate cancer scientists and researchers convene and share the latest unpublished new findings in the field. The proceedings of the pcf scientific retreat are shared with the world's cancer research community on www.pcf.org. Pcf facilitates various online forums where those touched by prostate cancer can tell their stories and seek solace in the shared experiences of others. We want men and women alike to talk about this disease, to understand its urgency, and to have information-driven hope. Through pcf.org, we provide unique resources that help men during their critical journey. In 2020, pcf also reached a greater number of patients and families through the distribution of the pcf prostate cancer patient guide, a must-have resource. Compiled with the contributions of top-tier doctors and researchers in prostate cancer, it focuses all of the information available about contemporary prostate cancer research, treatment, and lifestyle factors into one consolidated document. In 2020, pcf updated the prostate cancer patient guide with an appendix describing possible changes to patient care during the covid-19 pandemic, at each stage of disease. Pcf also advocates for greater awareness of prostate cancer. This past year, our work raising awareness and funds for medical research progress against prostate cancer was accomplished by several initiatives and movements harnessing the collective power of those touched by prostate cancer with the scientists working to defeat it. During pcf's annual home run challenge, pcf launched the "walk the bases" campaign to raise vital awareness and funds for life-saving research. The 41.5 miles in june: walk the bases challenge provided a fun new way for families impacted by prostate cancer to connect, find support, and stay active during the pandemic. In 2020, nih and pcf continued to partner on the largest study of aggressive prostate cancer in black men. Pcf is committed to advancing health equity and justice and raising awareness about prostate cancer in the b”

“During the filing year compensation for jonathan w. Simons, m.d., ceo and president, exceeded $1 million in remuneration. The form 4720 is not required to be filed by the organization as a portion of his compensation qualifies as exempt income under i.r.c. 4960(c)(3)(b) exemption for remuneration for medical services.”

“AWARD REFUNDS 161,582.”